Evolution of incretin-based therapies: From GLP-1 monotherapy to dual and triple agonists
Key Takeaways Weight loss shots with B12 is a broad term covering pure B12 injections, MIC shots, Lipo-C shots, and other compounded formulas each with different evidence bases Pure B12 injections do not cause weight loss in people with normal B12 levels the clinical benefit in deficient patients is real but indirect MIC shots and lipotropic injections have weak clinical evidence the Obesity Medicine Association does not list them among evidence-based obesity treatments Always get a serum B12 blood test before booking clinic injections if your levels are normal, B12 shots will not change your weight MIC shots are not FDA-approved for weight loss and formulas vary significantly between clinics People on long-term metformin, vegans, post-bariatric surgery patients, and adults over 65 are at highest risk of genuine B12 deficiency and benefit most from injections For injection-based weight loss with robust clinical evidence, GLP-1 medications like semaglutide are the current standard of care References Green R, Allen LH, Bjorke-Monsen AL, et al
This was so easy to order, and fill out my new patient paperwork from my phone
Sermorelin was first approved by the FDA as a medication called Geref to treat GH deficiency in children
Research demonstrates that vitamin D deficiency affects nearly one billion people worldwide [6] and significantly impacts various forms of hair loss
Value-Based Payment Models Healthcare payers are increasingly moving toward value-based payment models, which reward quality and efficiency rather than just the volume of services provided
